Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: Possible association with disease progression via interleukin-17 production

Journal of Interferon and Cytokine Research

Volumn 33, Issue 7, 2013, Pages 398-401

  Tian, Ye ^a   Shen, Hui ^a   Xia, Liping ^a   Lu, Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 17; INTERLEUKIN 34; PEPTIDE ANTIBODY; RHEUMATOID FACTOR; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; TREATMENT DURATION;

ADULT; AGED; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; BLOOD PROTEINS; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERLEUKIN-17; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SYNOVIAL MEMBRANE; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880234773     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0122     Document Type: Article

References (15)

1. Arnett FC, Edworthy SM, Bloch DA, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324. (Pubitemid 18091653)
2. Chemel M, Le Goff B, Brion R, et al. 2012. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis 71:150-154.
3. Chen Z, Buki K, Vaaraniemi J, et al. 2011. The critical role of IL-34 in osteoclastogenesis. PLoS One 6:e18689.
4. Droin N, Solary E. 2010. Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebrates. J Leukoc Biol 87:745-747.
5. Eda H, Zhang J, Keith RH, et al. 2010. Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine 52:215-220.
6. Hamilton JA. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immuno l8:533-544. (Pubitemid 351913679)
7. Lin H, Lee E, Hestir K, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320:807-811. (Pubitemid 351929632)
8. Niedbala W, Cai B, Wei X, et al. 2008. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 67:1474-1479.
9. Niedbala W, Wei XQ, Cai B, et al. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37:3021-3029. (Pubitemid 350131282)
10. Palmer G, Talabot-Ayer D, Lamacchia C, et al. 2009. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 60:738-749.
11. Seeuws S, Jacques P, Van Praet J, et al. 2010. A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Res Ther 12:R160.
12. Shen H, Goodall JC, Hill Gaston JS. 2009. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 60:1647-1656.
13. Shen H, Xia L, Xiao W, et al. 2011. Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arthritis Rheum 63:860-861.
14. Xiangyang Z, Lutian Y, Lin Z, et al. 2012. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 58:6-9.
15. Yang L, Anderson DE, Baecher-Allan C, et al. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350-352.